EDAP TMS S.A. (EDAP)
USD 2.16
(-12.2%)
USD 2.16
(-12.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.78 Million EUR | -13.11% |
| 2022 | 6.65 Million EUR | -18.46% |
| 2021 | 8.16 Million EUR | 50.2% |
| 2020 | 5.43 Million EUR | -37.26% |
| 2019 | 8.66 Million EUR | 28.35% |
| 2018 | 6.74 Million EUR | 43.03% |
| 2017 | 4.71 Million EUR | 70.76% |
| 2016 | 2.76 Million EUR | -33.37% |
| 2015 | 4.14 Million EUR | 31.4% |
| 2014 | 3.15 Million EUR | 1.84% |
| 2013 | 3.09 Million EUR | -61.67% |
| 2012 | 8.08 Million EUR | -37.59% |
| 2011 | 12.95 Million EUR | -9.9% |
| 2010 | 14.38 Million EUR | -10.46% |
| 2009 | 16.06 Million EUR | 15.66% |
| 2008 | 13.88 Million EUR | -6.94% |
| 2007 | 14.92 Million EUR | 345.04% |
| 2006 | 3.35 Million EUR | 22.75% |
| 2005 | 2.73 Million EUR | 19.36% |
| 2004 | 2.28 Million EUR | 27.4% |
| 2003 | 1.79 Million EUR | -7.88% |
| 2002 | 1.94 Million EUR | -16.47% |
| 2001 | 2.33 Million EUR | -60.91% |
| 2000 | 5.97 Million EUR | -32.24% |
| 1999 | 8.81 Million EUR | -3.41% |
| 1998 | 9.12 Million EUR | 356.17% |
| 1997 | 1.99 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 5.28 Million EUR | -22.83% |
| 2024 Q1 | 6.84 Million EUR | 18.36% |
| 2023 Q2 | 5.16 Million EUR | -8.07% |
| 2023 FY | 5.78 Million EUR | -13.11% |
| 2023 Q4 | 5.78 Million EUR | 6.71% |
| 2023 Q1 | 5.61 Million USD | -15.63% |
| 2023 Q3 | 5.41 Million EUR | 4.98% |
| 2022 FY | 6.65 Million EUR | -18.46% |
| 2022 Q4 | 6.65 Million EUR | -2.72% |
| 2022 Q2 | 7.72 Million EUR | 10.84% |
| 2022 Q1 | 6.96 Million EUR | -14.63% |
| 2022 Q3 | 6.84 Million EUR | -11.42% |
| 2021 Q1 | 4.22 Million EUR | -22.21% |
| 2021 FY | 8.16 Million EUR | 50.2% |
| 2021 Q2 | 8.07 Million EUR | 91.08% |
| 2021 Q4 | 8.16 Million EUR | 3.09% |
| 2021 Q3 | 7.91 Million EUR | -1.98% |
| 2020 FY | 5.43 Million EUR | -37.26% |
| 2020 Q4 | 5.43 Million EUR | 23.44% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | - EUR | 0.0% |
| 2020 Q3 | 4.4 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | - EUR | 0.0% |
| 2019 FY | 8.66 Million EUR | 28.35% |
| 2019 Q4 | 8.66 Million EUR | 0.0% |
| 2019 Q3 | - EUR | 0.0% |
| 2018 Q2 | 4.42 Million EUR | 0.0% |
| 2018 FY | 6.74 Million EUR | 43.03% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q4 | 6.74 Million EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2017 FY | 4.71 Million EUR | 70.76% |
| 2017 Q3 | - EUR | -100.0% |
| 2017 Q4 | 4.71 Million EUR | 0.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q2 | 2.27 Million EUR | 0.0% |
| 2016 Q2 | 2.24 Million EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 FY | 2.76 Million EUR | -33.37% |
| 2016 Q4 | 2.76 Million EUR | 0.0% |
| 2016 Q3 | - EUR | -100.0% |
| 2015 Q3 | - EUR | -100.0% |
| 2015 Q4 | 4.14 Million EUR | 0.0% |
| 2015 Q1 | - EUR | -100.0% |
| 2015 FY | 4.14 Million EUR | 31.4% |
| 2015 Q2 | 3.88 Million EUR | 0.0% |
| 2014 Q1 | - EUR | -100.0% |
| 2014 Q4 | 3.15 Million EUR | 0.0% |
| 2014 FY | 3.15 Million EUR | 1.84% |
| 2014 Q3 | - EUR | -100.0% |
| 2014 Q2 | 3.09 Million EUR | 0.0% |
| 2013 Q2 | 2.78 Million EUR | 0.0% |
| 2013 FY | 3.09 Million EUR | -61.67% |
| 2013 Q4 | 3.09 Million EUR | 0.0% |
| 2013 Q3 | - EUR | -100.0% |
| 2013 Q1 | - EUR | -100.0% |
| 2012 Q3 | - EUR | -100.0% |
| 2012 Q2 | 3.64 Million EUR | 0.0% |
| 2012 FY | 8.08 Million EUR | -37.59% |
| 2012 Q4 | 8.08 Million EUR | 0.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2011 Q1 | - EUR | -100.0% |
| 2011 Q2 | 10.8 Million EUR | 0.0% |
| 2011 Q3 | - EUR | -100.0% |
| 2011 Q4 | 12.95 Million EUR | 0.0% |
| 2011 FY | 12.95 Million EUR | -9.9% |
| 2010 Q2 | 14.99 Million EUR | 0.0% |
| 2010 Q1 | - EUR | -100.0% |
| 2010 FY | 14.38 Million EUR | -10.46% |
| 2010 Q4 | 14.38 Million EUR | 0.0% |
| 2009 FY | 16.06 Million EUR | 15.66% |
| 2009 Q3 | - EUR | -100.0% |
| 2009 Q1 | - EUR | -100.0% |
| 2009 Q2 | 13.37 Million EUR | 0.0% |
| 2009 Q4 | 16.06 Million EUR | 0.0% |
| 2008 FY | 13.88 Million EUR | -6.94% |
| 2008 Q2 | 12.09 Million EUR | 0.0% |
| 2008 Q3 | - EUR | -100.0% |
| 2008 Q4 | 13.88 Million EUR | 0.0% |
| 2007 Q4 | 14.92 Million EUR | 308.06% |
| 2007 FY | 14.92 Million EUR | 345.04% |
| 2007 Q3 | 3.65 Million EUR | 0.0% |
| 2006 Q1 | - EUR | -100.0% |
| 2006 Q3 | - EUR | -100.0% |
| 2006 Q2 | 2.22 Million EUR | 0.0% |
| 2006 FY | 3.35 Million EUR | 22.75% |
| 2006 Q4 | 3.35 Million EUR | 0.0% |
| 2005 Q2 | - EUR | 0.0% |
| 2005 Q4 | 2.73 Million EUR | 0.0% |
| 2005 Q1 | - EUR | -100.0% |
| 2005 FY | 2.73 Million EUR | 19.36% |
| 2004 Q2 | - EUR | 0.0% |
| 2004 FY | 2.28 Million EUR | 27.4% |
| 2004 Q3 | - EUR | 0.0% |
| 2004 Q4 | 2.28 Million EUR | 0.0% |
| 2004 Q1 | - EUR | -100.0% |
| 2003 Q2 | - EUR | 0.0% |
| 2003 Q3 | - EUR | 0.0% |
| 2003 Q4 | 1.79 Million EUR | 0.0% |
| 2003 Q1 | - EUR | -100.0% |
| 2003 FY | 1.79 Million EUR | -7.88% |
| 2002 Q2 | - EUR | 0.0% |
| 2002 FY | 1.94 Million EUR | -16.47% |
| 2002 Q3 | - EUR | 0.0% |
| 2002 Q4 | 1.94 Million EUR | 0.0% |
| 2002 Q1 | - EUR | -100.0% |
| 2001 Q3 | - EUR | -100.0% |
| 2001 Q1 | 3.13 Million EUR | -47.58% |
| 2001 Q2 | 430 Thousand EUR | -86.26% |
| 2001 Q4 | 2.33 Million EUR | 0.0% |
| 2001 FY | 2.33 Million EUR | -60.91% |
| 2000 FY | 5.97 Million EUR | -32.24% |
| 2000 Q2 | 5.53 Million EUR | -7.99% |
| 2000 Q3 | 5.41 Million EUR | -2.17% |
| 2000 Q4 | 5.97 Million EUR | 10.37% |
| 2000 Q1 | 6.01 Million EUR | -31.8% |
| 1999 Q4 | 8.81 Million EUR | 0.0% |
| 1999 FY | 8.81 Million EUR | -3.41% |
| 1998 FY | 9.12 Million EUR | 356.17% |
| 1998 Q4 | 9.12 Million EUR | 0.0% |
| 1997 FY | 1.99 Million EUR | 0.0% |
| 1997 Q4 | 1.99 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 98.932% |
| Nemaura Medical Inc. | 20.03 Million USD | 71.13% |
| NeuroPace, Inc. | 72.39 Million USD | 92.012% |
| LENSAR, Inc. | 2.3 Million USD | -150.444% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 21.28% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -262.556% |
| Apyx Medical Corporation | 38.5 Million USD | 84.98% |
| Cutera, Inc. | 431.91 Million USD | 98.661% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 63.009% |
| BioSig Technologies, Inc. | 452 Thousand USD | -1179.372% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 85.256% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.656% |
| Axonics, Inc. | 27.61 Million USD | 79.061% |
| IRIDEX Corporation | 2.74 Million USD | -110.589% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 92.699% |
| TELA Bio, Inc. | 42.78 Million USD | 86.483% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -1467.144% |
| RxSight, Inc. | 3.01 Million USD | -91.991% |
| Align Technology, Inc. | 96.96 Million USD | 94.036% |
| INVO Bioscience, Inc. | 8.68 Million USD | 33.406% |
| electroCore, Inc. | 626 Thousand USD | -823.764% |
| Telesis Bio, Inc. | 34.38 Million USD | 83.18% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 43.699% |
| Quipt Home Medical Corp. | 98.94 Million USD | 94.155% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 80.085% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -146.285% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 62.093% |
| Dynatronics Corporation | 6.68 Million USD | 13.535% |
| Modular Medical, Inc. | 1.19 Million USD | -385.946% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -2107.161% |
| Talis Biomedical Corporation | 19.66 Million USD | 70.598% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -323.633% |
| InMode Ltd. | 9.01 Million USD | 35.868% |
| Envoy Medical, Inc. | 404 Thousand USD | -1331.377% |
| Bruker Corporation | 1.37 Billion USD | 99.581% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -10045.198% |
| DexCom, Inc. | 2.59 Billion USD | 99.777% |
| Nexalin Technology, Inc. | 4463.00 USD | -129471.208% |
| PAVmed Inc | 48.72 Million USD | 88.132% |
| Viveve Medical, Inc. | 5.34 Million USD | -8.109% |
| Cerus Corporation | 95.99 Million USD | 93.976% |
| Movano Inc. | 252 Thousand USD | -2194.747% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 82.568% |
| Nexalin Technology, Inc. | 4463.00 USD | -129471.208% |
| IceCure Medical Ltd | 599 Thousand USD | -865.403% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 98.609% |
| enVVeno Medical Corporation | 1.4 Million USD | -312.465% |
| 908 Devices Inc. | 5.94 Million USD | 2.729% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 58.52% |
| Orthofix Medical Inc. | 134.19 Million USD | 95.691% |
| Surmodics, Inc. | 29.4 Million USD | 80.334% |
| Nuwellis, Inc. | 981 Thousand USD | -489.476% |
| Outset Medical, Inc. | 136.18 Million USD | 95.754% |
| Venus Concept Inc. | 79.69 Million USD | 92.744% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 95.546% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 91.775% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 31.125% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -514.981% |
| Inogen, Inc. | 21.92 Million USD | 73.622% |
| IRadimed Corporation | 2.04 Million USD | -183.047% |
| MaxCyte, Inc. | 18.74 Million USD | 69.147% |
| Pulmonx Corporation | 41.42 Million USD | 86.04% |
| PAVmed Inc. | 48.72 Million USD | 88.132% |
| iCAD, Inc. | 461 Thousand USD | -1154.395% |
| OrthoPediatrics Corp. | 23.76 Million USD | 75.662% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -189.645% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -1075.38% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -3035.989% |
| SI-BONE, Inc. | 38.99 Million USD | 85.169% |
| Semler Scientific, Inc. | 70 Thousand USD | -8161.09% |
| Beyond Air, Inc. | 17.83 Million USD | 67.58% |
| FONAR Corporation | 41.67 Million USD | 86.124% |
| AxoGen, Inc. | 69.29 Million USD | 91.655% |
| Biotricity, Inc. | 23.87 Million USD | 75.783% |
| Cytosorbents Corporation | 18.31 Million USD | 68.423% |
| ZimVie Inc. | 521.92 Million USD | 98.892% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 88.521% |
| Inari Medical, Inc. | 32.04 Million USD | 81.955% |
| UFP Technologies, Inc. | 46.03 Million USD | 87.439% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -189.645% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -88.298% |
| Sight Sciences, Inc. | 35.41 Million USD | 83.671% |
| Insulet Corporation | 1.44 Billion USD | 99.601% |
| Profound Medical Corp. | 7.9 Million USD | 26.804% |
| Bioventus Inc. | 409.47 Million USD | 98.588% |
| InspireMD, Inc. | 1.59 Million USD | -262.556% |
| BrainsWay Ltd. | 471 Thousand USD | -1127.763% |
| BIOLASE, Inc. | 17.91 Million USD | 67.712% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -458.0% |
| Tenon Medical, Inc. | 1.17 Million USD | -392.989% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -477.122% |
| CVRx, Inc. | 30.61 Million USD | 81.11% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.748% |
| Sintx Technologies, Inc. | 4.24 Million USD | -36.225% |
| Acutus Medical, Inc. | 38.47 Million USD | 84.972% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -189.863% |
| NanoVibronix, Inc. | 5000.00 USD | -115555.26% |
| Quanterix Corporation | 41.46 Million USD | 86.054% |
| LivaNova PLC | 640.4 Million USD | 99.097% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -93.367% |
| Varex Imaging Corporation | 469.5 Million USD | 98.768% |
| Vivani Medical, Inc. | 20.69 Million USD | 72.059% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -146.285% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -638.539% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.381% |
| TransMedics Group, Inc. | 515.94 Million USD | 98.879% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -203.876% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -2300.722% |
| Spectral AI, Inc. | 1.28 Million USD | -348.624% |
| Hyperfine, Inc. | 185 Thousand USD | -3025.818% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 96.992% |
| Biomerica, Inc. | 785 Thousand USD | -636.658% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -1186.537% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -1462.466% |
| Silk Road Medical, Inc | 84.63 Million USD | 93.167% |